Company / R&D per Share
Q32 Bio Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.95
FY2025
5-year range
$1.63 / $88.24
FY2021-FY2025
Trend
-95.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 8 years, ranging from $1.28 in FY2019 to $88.24 in FY2024.
Based on SEC 10-K filings.
3.95 in FY2025 with a 5-year CAGR of +14.8%.
Improved from $1.71 to $3.95 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +34.3%
- 5-Year CAGR
- +14.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 95.5% year-over-year.
- Peak r&d per share was recorded in FY2024.
- Lowest r&d per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.95 | -95.5% |
| FY2024 | $88.24 | +5057.5% |
| FY2023 | $1.71 | +5.0% |
| FY2022 | $1.63 | -18.4% |
| FY2021 | $2.00 | +0.8% |
| FY2020 | $1.98 | +54.4% |
| FY2019 | $1.28 | -84.2% |
| FY2018 | $8.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026